# ROYALTY PHARMA PLC Royalty Pharma PLC

ROYALTY PHARMA PLC Royalty Pharma PLC is a security (CUSIP 78081BAM5) tracked across SEC portfolio filings. 4 registered fund positions totaling $4.0M via N-PORT as of 2026-05-29.

## Summary

- Issuer: ROYALTY PHARMA PLC
- Class: Royalty Pharma PLC
- CUSIP: 78081BAM5
- Asset category: DBT
- 13F holders: 0
- N-PORT fund positions: 4
- N-PORT value: $4.0M
- N-PORT report: 2026-05-29

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Select Bond Portfolio](https://search.stillhousedata.com/fund/S000000047) | NORTHWESTERN MUTUAL SERIES FUND INC | $1.5M | 5.20% |
| Guggenheim Strategic Opportunities Fund | Guggenheim Strategic Opportunities Fund | $1.5M | 6.10% |
| [Corporate Bond Portfolio](https://search.stillhousedata.com/fund/S000004118) | MORGAN STANLEY INSTITUTIONAL FUND TRUST | $540K | 34.95% |
| [VANGUARD BALANCED INDEX FUND](https://search.stillhousedata.com/fund/S000002560) | VANGUARD VALLEY FORGE FUNDS | $540K | 0.09% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/78081BAM5.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.